Related Experiment Videos
Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
1VA Central California Health Care System, Fresno, USA.
Insights
Drug therapy to control high cholesterol in older adults is beneficial. Lipid-lowering treatments reduce coronary heart disease risks, justifying intervention and identification of untreated patients.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Older individuals with hypercholesterolemia face increased risks of coronary heart disease (CHD) morbidity and mortality.
- This risk escalates with advancing age, highlighting a critical need for effective management strategies.
Purpose of the Study:
- To evaluate the efficacy and justification of cholesterol-controlling drug therapy in older populations.
- To emphasize the importance of identifying and treating hypercholesterolemia in the elderly.
Main Methods:
- Review of accumulating evidence and recent clinical trials on lipid-lowering therapy in older persons.
- Analysis of CHD risk factors and outcomes associated with hypercholesterolemia in aging individuals.
Main Results:
- Evidence supports the benefit of cholesterol control in older adults, similar to younger patients.
- Lipid-lowering therapy demonstrates significant advantages for older individuals regarding CHD risk reduction.
Conclusions:
- Controlling cholesterol levels through drug therapy is a worthwhile goal for older persons.
- Greater vigilance in identifying and treating hypercholesterolemia in the elderly is warranted.
- Intervention with lipid-lowering therapy is justified for older adults at risk of CHD.
Abstract:
Despite some indications to the contrary, evidence continues to accumulate that controlling cholesterol levels with drug therapy in older persons is a worthwhile goal. Older persons with hypercholesterolemia have an elevated risk of coronary heart disease morbidity and mortality, and this risk increases as they age. Recent clinical trials have suggested that older persons benefit from lipid-lowering therapy as much as younger patients do. Therefore, intervention appears to be justified--as is greater vigilance in identifying untreated patients.